Microbiome-pathogen interactions drive epidemiological dynamics of antibiotic resistance: A modeling study applied to nosocomial pathogen control.
David R M SmithLaura TemimeLulla OpatowskiPublished in: eLife (2021)
The human microbiome can protect against colonization with pathogenic antibiotic-resistant bacteria (ARB), but its impacts on the spread of antibiotic resistance are poorly understood. We propose a mathematical modeling framework for ARB epidemiology formalizing within-host ARB-microbiome competition, and impacts of antibiotic consumption on microbiome function. Applied to the healthcare setting, we demonstrate a trade-off whereby antibiotics simultaneously clear bacterial pathogens and increase host susceptibility to their colonization, and compare this framework with a traditional strain-based approach. At the population level, microbiome interactions drive ARB incidence, but not resistance rates, reflecting distinct epidemiological relevance of different forces of competition. Simulating a range of public health interventions (contact precautions, antibiotic stewardship, microbiome recovery therapy) and pathogens (Clostridioides difficile, methicillin-resistant Staphylococcus aureus, multidrug-resistant Enterobacteriaceae) highlights how species-specific within-host ecological interactions drive intervention efficacy. We find limited impact of contact precautions for Enterobacteriaceae prevention, and a promising role for microbiome-targeted interventions to limit ARB spread.
Keyphrases
- multidrug resistant
- methicillin resistant staphylococcus aureus
- public health
- healthcare
- gram negative
- physical activity
- klebsiella pneumoniae
- acinetobacter baumannii
- risk factors
- drug resistant
- staphylococcus aureus
- pseudomonas aeruginosa
- endothelial cells
- escherichia coli
- stem cells
- candida albicans
- drug delivery
- antimicrobial resistance
- cancer therapy
- urinary tract infection
- cell therapy
- social media
- global health
- smoking cessation
- acute care